Condition
Malignant Pleural Mesotheliomas
Estimated Enrollment: 50
Age Group: 39 Years to 84 Years (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Cohort|Time Perspective: Retrospective
Study ID Numbers: DR-81
Study First Received: October 28, 2015
Last Updated: May 29, 2016
Estimated Primary Completion Date: May 2016
Primary Outcome Measures:
to correlate the results of the vascularity marker of pleural mesothelioma CD74 of patients attended to Ain Shams University hospitals with the result response of treatment by chemotherapy ,overall survival and progreeion free survival|assessment of vascular enothelial growth factor (VEGF) in patient with malignant pleural mesothelioma who attended to Ain Shams University and made comparison with the result of CD 74
Sponsors and Collaborators:
Ain Shams University
Website Link: https://ClinicalTrials.gov/show/NCT02603315
